Flournoy N - Search Results

1

Comparison of Isotonic Designs for Dose-Finding.

Ivanova A, Flournoy N. Ivanova A, et al. Among authors: flournoy n. Stat Biopharm Res. 2009 Feb 1;1(1):101. doi: 10.1198/sbr.2009.0010. Stat Biopharm Res. 2009. PMID: 20157632 Free PMC article.

2

Dose finding using the biased coin up-and-down design and isotonic regression.

Stylianou M, Flournoy N. Stylianou M, et al. Among authors: flournoy n. Biometrics. 2002 Mar;58(1):171-7. doi: 10.1111/j.0006-341x.2002.00171.x. Biometrics. 2002. PMID: 11890313

3

Estimating the probability of toxicity at the target dose following an up-and-down design.

Stylianou M, Proschan M, Flournoy N. Stylianou M, et al. Among authors: flournoy n. Stat Med. 2003 Feb 28;22(4):535-43. doi: 10.1002/sim.1351. Stat Med. 2003. PMID: 12590412

4

A random walk rule for phase I clinical trials.

Durham SD, Flournoy N, Rosenberger WF. Durham SD, et al. Among authors: flournoy n. Biometrics. 1997 Jun;53(2):745-60. Biometrics. 1997. PMID: 9192462

5

Quantile estimation following non-parametric phase I clinical trials with ordinal response.

Paul RK, Rosenberger WF, Flournoy N. Paul RK, et al. Among authors: flournoy n. Stat Med. 2004 Aug 30;23(16):2483-95. doi: 10.1002/sim.1834. Stat Med. 2004. PMID: 15287079

6

The analysis of failure times in the presence of competing risks.

Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. Prentice RL, et al. Among authors: flournoy n. Biometrics. 1978 Dec;34(4):541-54. Biometrics. 1978. PMID: 373811

7

Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy.

Petersen FB, Appelbaum FR, Buckner CD, Sanders JE, Clift RA, McGuffin R, Bearman SI, Flournoy N, Thomas ED. Petersen FB, et al. Among authors: flournoy n. Bone Marrow Transplant. 1988 Nov;3(6):619-24. Bone Marrow Transplant. 1988. PMID: 3063329

8

Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R. Weiden PL, et al. Among authors: flournoy n. N Engl J Med. 1979 May 10;300(19):1068-73. doi: 10.1056/NEJM197905103001902. N Engl J Med. 1979. PMID: 34792

9

Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients.

Shepp DH, Dandliker PS, Flournoy N, Meyers JD. Shepp DH, et al. Among authors: flournoy n. Transplantation. 1987 May;43(5):654-8. doi: 10.1097/00007890-198705000-00010. Transplantation. 1987. PMID: 3554658 Clinical Trial.

10

Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection.

Schubert MM, Peterson DE, Flournoy N, Meyers JD, Truelove EL. Schubert MM, et al. Among authors: flournoy n. Oral Surg Oral Med Oral Pathol. 1990 Sep;70(3):286-93. doi: 10.1016/0030-4220(90)90142-f. Oral Surg Oral Med Oral Pathol. 1990. PMID: 2170891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters